US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

210.78

-21.2100-9.14%

Post-market: 212.771.99+0.94%19:59 EDT

Volume:426.63K

Turnover:92.65M

Market Cap:563.73M

PE:- -

High:229.00

Open:229.00

Low:210.16

Close:231.99

52wk High:341.93

52wk Low:102.35

Shares:2.67M

Float Shares:2.67M

Volume Ratio:0.68

T/O Rate:15.95%

Dividend:0.90

Dividend Rate:0.43%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sigma Healthcare Details ESG Strategy in 2026 Sustainability Report

Lupin Gets US FDA Approval for Vitamin K Injection

MT Newswires Live

Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes

Wall Street Analysts Are Bullish on Top Healthcare Picks

Mayne Pharma Group Receives US FDA Confirmation on Fulfillment of Post-Marketing Requirement for Vaginal Inserts

MT Newswires Live

Genesis Healthcare Clears Path for $1 Billion Bankruptcy Sale

Golden Globe Resources Rectifies Late Director Interest Disclosures

FDA clears IMVEXXY post-marketing obligations as Mayne Pharma targets U.S. menopause growth

Stocks to Watch: SpaceX, AT&T, Verizon, T-Mobile, Alignment Healthcare, CVS Health

Mesoblast Limited (MEOBF) Receives a Buy from Bell Potter

Acrux to Brief Investors on Female Testosterone MDTS and FDA Feedback

Health Care Down as Michigan Files Suit Against Insurer

Health Care Roundup: Market Talk

Gould Holdings lifts stake in Promisia Healthcare to 16.7%

RBC would be buyers of Revolution Medicines after FDA docs ‘overreaction’

3 Australian Undervalued Stocks To Watch With Up To 35% Fair Value Upside

Simply Wall St.

Lupin Wins U.S. FDA Nod for Generic Phytonadione Injectable

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

FDA approves Genentech’s atezolizumab combo for Stage III dMMR colon cancer

Sector Update: Healthcare

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":210.78,"timestamp":1791921600000,"preClose":231.99,"halted":0,"volume":426634,"hourTrading":{"tag":"盘后","latestPrice":212.77,"preClose":210.78,"latestTime":"19:59 EDT","volume":16334,"amount":3477575.9866,"timestamp":1791935972818,"change":1.99,"changeRate":0.009441,"amplitude":0.012904},"delay":0,"changeRate":-0.09142635458424936,"floatShares":2674486,"shares":2674486,"eps":0,"marketStatus":"Closed","change":-21.21,"latestTime":"10-13 16:00:00 EDT","open":229,"high":229,"low":210.1596,"amount":92647400.00698,"amplitude":0.081212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":231.99,"sharesOutstanding":3074486,"nav":231.877,"aum":620152459.74,"dividendRate":0.004293,"bidAskSpread":0.003009,"preHourTrading":{"tag":"盘前","latestPrice":228,"preClose":231.99,"latestTime":"09:29 EDT","volume":2274,"amount":529315.02324,"timestamp":1791898190029,"change":-3.99,"changeRate":-0.017199,"amplitude":0.03664},"postHourTrading":{"tag":"盘后","latestPrice":212.77,"preClose":210.78,"latestTime":"19:59 EDT","volume":16334,"amount":3477575.9866,"timestamp":1791935972818,"change":1.99,"changeRate":0.009441,"amplitude":0.012904},"volumeRatio":0.679063,"impliedVol":0.9697,"impliedVolPercentile":0.7131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2674486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.679063,"shares":2674486,"dividePrice":0.9048,"high":229,"amplitude":0.081212,"preClose":231.99,"low":210.1596,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":210.78,"eps":0,"divideRate":0.004293,"volume":426634,"delay":0,"ttmEps":0,"open":229,"prevYearClose":159.39,"prevWeekClose":243.09,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":230.95,"twentyDayClose":250.4,"sixtyDayClose":249.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674280835","title":"Sigma Healthcare Details ESG Strategy in 2026 Sustainability Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2674280835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674280835?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:14","pubTimestamp":1791526470,"startTime":"0","endTime":"0","summary":"Sigma Healthcare Ltd ( ($AU:SIG) ) has shared an announcement. Sigma Healthcare has released its 2026 Sustainability Report, outlining how it manag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-details-esg-strategy-in-2026-sustainability-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-details-esg-strategy-in-2026-sustainability-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","BK4581","BK4137","IVRA","LABU","LU0128526141.USD","HCSG","LU0029874061.USD","PRXI","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674887430","title":"Lupin Gets US FDA Approval for Vitamin K Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2674887430","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674887430?lang=en_us&edition=fundamental","pubTime":"2026-10-09 11:21","pubTimestamp":1791516097,"startTime":"0","endTime":"0","summary":"Lupin  received U.S. Food and Drug Administration approval for its Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL single-dose prefilled syringe, according to a Thursday exchange filing.The product is bioequivalent to International Medication Systems' reference drug and is indicated for treating and preventing low blood clotting and vitamin K deficiency, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674184887","title":"Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes","url":"https://stock-news.laohu8.com/highlight/detail?id=2674184887","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674184887?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:52","pubTimestamp":1791514334,"startTime":"0","endTime":"0","summary":"Linical Co., Ltd. ( ($JP:2183) ) has issued an update. Linical Co., Ltd. has secured a large new order from a U.S. biotechnology company worth 20.4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","BK4588","AGNG","LABU","DARP","XBI","BK4581","IEIH","XT","BK4585","RSPH","FHLC","BBP","PBE","JDOC","FWD","IBB","SYNB","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674823408","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2674823408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674823408?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:50","pubTimestamp":1791510620,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CSL (CMXHF), Ionis Pharmaceuticals (IONS) and Cormed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-375?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-375?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMXHF","LU0128526141.USD","BK4588","LABU","BK4585","IONS","BK4581","XBI","HCSG","BK4137","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674886132","title":"Mayne Pharma Group Receives US FDA Confirmation on Fulfillment of Post-Marketing Requirement for Vaginal Inserts","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886132","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674886132?lang=en_us&edition=fundamental","pubTime":"2026-10-09 08:05","pubTimestamp":1791504310,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  received a letter from the US Food and Drug Administration  confirming the company's fulfillment of its post-marketing requirement safety study for IMVEXXY vaginal inserts, according to a Friday filing with the Australian bourse.IMVEXXY is approved by the FDA for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause, the filing said.The study showed that there's no link between very-low-dose vaginal estrogen products and endometrial cancer risk in postmenopausal women, per the filing.Shares fell 2% in morning trade Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","LABU","BK7508","BK7096","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885295","title":"Genesis Healthcare Clears Path for $1 Billion Bankruptcy Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885295","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674885295?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:18","pubTimestamp":1791501480,"startTime":"0","endTime":"0","summary":"Genesis Healthcare won bankruptcy court approval Thursday to amend its roughly $1 billion asset sale to 101 W. State Street, resolving last-minute disputes that threatened to cut $100 million from the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","GENNQ","LU0029874061.USD","LU1883839398.USD","HCSG","BK4588","BK4137","BK4581","BK4135","BK4585","STT","XLV","XBI","IE00B64PRP62.GBP","LABU","LU1894683264.USD","IE0034235188.USD","LU0061475181.USD","IE00BGHQF748.EUR","LU1894683348.USD","LU0128526141.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885474","title":"Golden Globe Resources Rectifies Late Director Interest Disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885474","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674885474?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:17","pubTimestamp":1791501456,"startTime":"0","endTime":"0","summary":"An update from Reckon Health Care Holdings Ltd ( ($AU:GGR) ) is now available. Golden Globe Resources has disclosed that it failed to lodge initial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-rectifies-late-director-interest-disclosures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/golden-globe-resources-rectifies-late-director-interest-disclosures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","XLV","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885445","title":"FDA clears IMVEXXY post-marketing obligations as Mayne Pharma targets U.S. menopause growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885445","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674885445?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:03","pubTimestamp":1791500594,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group ( ($AU:MYX) ) has issued an announcement. Mayne Pharma has secured confirmation from the U.S. Food and Drug Administration that ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-clears-imvexxy-post-marketing-obligations-as-mayne-pharma-targets-u-s-menopause-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-clears-imvexxy-post-marketing-obligations-as-mayne-pharma-targets-u-s-menopause-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674788557","title":"Stocks to Watch: SpaceX, AT&T, Verizon, T-Mobile, Alignment Healthcare, CVS Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2674788557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674788557?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:50","pubTimestamp":1791499800,"startTime":"0","endTime":"0","summary":"SpaceX bought a portfolio of spectrum licenses from Grain Management. SpaceX shares gained 2.8%, to $165.04, while AT&T, Verizon, and T-Mobile US all saw their stocks drop about 6.6% after hours.Alignment Healthcare said one of its 2027 Medicare Advantage plans received a 3.5-star rating from the Centers for Medicare & Medicaid Services. Shares dropped 23%, to $6.70, after Thursday's closing bell.CVS Health's health-insurance business, Aetna, said more than 69% of its Medicare Advantage members are in 2027 plans that received ratings of at least four stars. The stock slid 3%, to $85.16, in after-hours trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPAL","YSPC","LU1116320901.HKD","LU1035773651.USD","MARS","WARP","XOVL","LU1064131342.USD","WSPC","SPCQ","LU1983299246.USD","DXYZ","LU0321505868.SGD","ALHC","BK4196","LU1585245621.USD","IE00BMPRXR70.SGD","SPCM","LU2360106780.USD","LNGR","RTH","LOFF","IE00BSNM7G36.USD","SSPC","UFO","XLV","ORBX","SPAX","VOX","SPCU","VZ","LU0225284248.USD","XBI","SPCH","XOVR","SPCF","LABU","SNK","DSPC","CVS","ELOL","IYZ","T","TMUS","SPCG","SPCX","LU1621768206.USD","LOFD","LU2461242641.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674841885","title":"Mesoblast Limited (MEOBF) Receives a Buy from Bell Potter","url":"https://stock-news.laohu8.com/highlight/detail?id=2674841885","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674841885?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:35","pubTimestamp":1791498922,"startTime":"0","endTime":"0","summary":"Bell Potter analyst John Hester maintained a Buy rating on Mesoblast Limited today and set a price target of A$4.45. Hester covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mesoblast-limited-meobf-receives-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mesoblast-limited-meobf-receives-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","XLV","MEOBF","BK4139","BK4585","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883759","title":"Acrux to Brief Investors on Female Testosterone MDTS and FDA Feedback","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674883759?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:14","pubTimestamp":1791497665,"startTime":"0","endTime":"0","summary":"An announcement from Acrux ( ($AU:ACR) ) is now available. Acrux has scheduled a live investor webinar on 12 October 2026 to brief shareholders on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrux-to-brief-investors-on-female-testosterone-mdts-and-fda-feedback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrux-to-brief-investors-on-female-testosterone-mdts-and-fda-feedback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","ISBC","BK4211","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674880548","title":"Health Care Down as Michigan Files Suit Against Insurer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674880548","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674880548?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:28","pubTimestamp":1791494880,"startTime":"0","endTime":"0","summary":"Health-care companies fell amid fears that health insurers would remain in regulatory crosshairs during the election season.Michigan's attorney general filed an antitrust suit against the state's largest health insurer Blue Cross Blue Shield of Michigan, citing monopolistic pricing practices.Among publicly traded health insurers, Humana and UnitedHealth Group lost ground.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTS","IE0002141913.USD","LU1057294990.SGD","SGXZ51526630.SGD","XLV","LABU","FXH","IHF","RXL","SUNH0main","BK4532","XBI","LU0162691827.USD","LU0072461881.USD","LU0097036916.USD","MHIP","UN","CURE","LU0965509010.AUD","RSPH","GDOC","SG9999018857.SGD","UNHU","LU2954938101.SGD","LU0053666078.USD","LU0158827781.USD","FHLC","JHMH","LU0211328371.USD","UNHG","LU0820561909.HKD","LU0976567544.SGD","PINK","LU0011850046.USD","UNH","UNHW","JDOC","LU0058720904.USD","TMED","VHT","LU1988902786.USD","LU0310800965.SGD","LU1153585028.USD","LU1732800096.USD","TRUH","RXD","IXJ","IYH","IE00B2B36J28.USD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888875","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888875","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888875?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:50","pubTimestamp":1791492600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0808 ET - GSK CEO Luke Miels sees the U.K. drugmaker's oncology ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XBI","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674700720","title":"Gould Holdings lifts stake in Promisia Healthcare to 16.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674700720","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674700720?lang=en_us&edition=fundamental","pubTime":"2026-10-09 03:47","pubTimestamp":1791488866,"startTime":"0","endTime":"0","summary":"Promisia Healthcare Limited ( ($NZ:PHL) ) has provided an update. Gould Holdings Limited has lifted its stake in Promisia Healthcare Limited to 16....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gould-holdings-lifts-stake-in-promisia-healthcare-to-16-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gould-holdings-lifts-stake-in-promisia-healthcare-to-16-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0029874061.USD","LU0128526141.USD","BK4137","XBI","XLV","HCSG","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674074190","title":"RBC would be buyers of Revolution Medicines after FDA docs ‘overreaction’","url":"https://stock-news.laohu8.com/highlight/detail?id=2674074190","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674074190?lang=en_us&edition=fundamental","pubTime":"2026-10-09 03:45","pubTimestamp":1791488724,"startTime":"0","endTime":"0","summary":"RBC Capital notes Revolution Medicines (RVMD) looks to be down in response to yesterday’s disclosure of FDA’s Rasonque review documents, particular...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rbc-would-be-buyers-of-revolution-medicines-after-fda-docs-overreaction-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rbc-would-be-buyers-of-revolution-medicines-after-fda-docs-overreaction-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSIB","IDNA","LU0029864427.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","CANC","BK4588","IE0009355771.USD","IE0002141913.USD","IE0009354923.USD","LU0320765992.SGD","RVMD","PTH","LU0708994859.HKD","LU0109394709.USD","LU1267930573.SGD","IE00BFTCPJ56.SGD","BK4585","LU0128525929.USD","BK4139","BK4207","LABU","LU0310800379.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674000189","title":"3 Australian Undervalued Stocks To Watch With Up To 35% Fair Value Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2674000189","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674000189?lang=en_us&edition=fundamental","pubTime":"2026-10-09 03:39","pubTimestamp":1791488353,"startTime":"0","endTime":"0","summary":"Global trade is getting a powerful new engine as the World Trade Organization highlights AI related products lifting goods flows despite conflict and higher energy costs. That backdrop matters for Australian companies with healthy cash generation and strong balance sheets that the market has not fully priced. This article breaks down three such high quality opportunities that screen as undervalued and explains why patient investors are watching them closely right now.\nThe three stocks below...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice1-card/1788945089957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice1-card/1788945089957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-vnt/ventia-services-group-shares/news/3-australian-undervalued-stocks-to-watch-with-up-to-35-fair","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-vnt/ventia-services-group-shares/news/3-australian-undervalued-stocks-to-watch-with-up-to-35-fair","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","VAS.AU","BBOZ.AU","QFN.AU","STW.AU","XJO.AU","VAP.AU","XAO.AU","XKO.AU","GIVE.AU","BEAR.AU","EIGA.AU","IMLC.AU","SLF.AU","BK4588","BK4581","PNI.AU","SIG.AU","E200.AU","OZR.AU","VNT.AU","XLV","XBI","BK7103","IIGF.AU","SPHQ","IOZ.AU","LABU","OZF.AU","BK7062","QRE.AU","ZYAU.AU","IISV.AU","BK7055","DACE.AU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674020830","title":"Lupin Wins U.S. FDA Nod for Generic Phytonadione Injectable","url":"https://stock-news.laohu8.com/highlight/detail?id=2674020830","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674020830?lang=en_us&edition=fundamental","pubTime":"2026-10-09 03:05","pubTimestamp":1791486320,"startTime":"0","endTime":"0","summary":"Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Lupin Limited has secured approval from the U.S. Food and Drug Administration for its Abb...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-nod-for-generic-phytonadione-injectable?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-nod-for-generic-phytonadione-injectable?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674023640","title":"Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2674023640","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674023640?lang=en_us&edition=fundamental","pubTime":"2026-10-09 02:10","pubTimestamp":1791483000,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Oct.  08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/08/3377628/0/en/tevogen-signs-letter-of-intent-to-evaluate-potential-acquisition-of-hrk-healthcare-llc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4585","NOBL","LABU","LU0029874061.USD","IXJ","BK4588","XLV","CGCV","TCAF","HCSG","XBI","BK4137","VHT","BK4581","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674300415","title":"FDA approves Genentech’s atezolizumab combo for Stage III dMMR colon cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674300415","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674300415?lang=en_us&edition=fundamental","pubTime":"2026-10-09 01:50","pubTimestamp":1791481815,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved atezolizumab, or Tecentriq, from Genentech, in combination with a fluoropyrimidine and oxaliplatin for th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-genentechs-atezolizumab-combo-for-stage-iii-dmmr-colon-cancer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-genentechs-atezolizumab-combo-for-stage-iii-dmmr-colon-cancer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674400173","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2674400173","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674400173?lang=en_us&edition=fundamental","pubTime":"2026-10-09 01:24","pubTimestamp":1791480268,"startTime":"0","endTime":"0","summary":"Healthcare stocks fell Thursday afternoon, with the NYSE Healthcare Index down 1% and the State Street Health Care Select Sector SPDR ETF  shedding 1%.The iShares Biotechnology ETF  fell 2%.In corporate news, Viatris  will acquire Pacira BioSciences  in an all-cash deal worth roughly $1.65 billion, as the healthcare company looks to strengthen its non-opioid pain management portfolio. Viatris shares were down 2%, and Pacira surged 44%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","LU0128526141.USD","LU1839511570.USD","BK4588","LU2087621335.USD","XLV","BK4583","VTRS","IBB","BK4007","LABU","LU0029874061.USD","BK4581","HCSG","PCRX","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":6,"totalSize":398,"code":"91000000","status":"200"}]}}